DoseBiome has developed a new probiotic that targets several aspects of oral health: dental caries, periodontal diseases, and halitosis. This project aims to understand the exact mechanism of our probiotic’s inhibitory properties against the pathogens associated with the above diseases. DoseBiome is a new start-up in the probiotic/microbiome health sector, and this project will allow for improved technology and manufacturing processes for our oral probiotic line.
William Wiley Navarre
Biochemistry / Molecular biology
University of Toronto
Find the perfect opportunity to put your academic skills and knowledge into practice!Find Projects